期刊文献+

咪达普利与缬沙坦对兔动脉粥样硬化相关因子表达的影响及意义 被引量:1

Effects and significance of imidapril and valsartan on atherosclerotic related factors in rabbits
下载PDF
导出
摘要 目的:研究咪达普利与缬沙坦对兔动脉中周期蛋白依赖激酶4(CDK4)、血管细胞黏附分子-1(VCAM-1)、信号转导及转录活化因子3(STAT3)和P15mRNA量的表达影响,探讨其抗动脉粥样硬化的机制。方法:48只雄性大白兔随机分为4组,对照组、高脂饮食组(高脂组)、高脂饮食加咪达普利组(咪达普利组)和高脂饮食加缬沙坦组(缬沙坦组)。喂养8周后处死兔子,测定各组血脂水平,并采用免疫组化法和RT-PCR法分别检测CDK4、VCAM-1、STAT3和P15mRNA量的表达。结果:高脂组、咪达普利组、缬沙坦组血清TC、TG、LDL-C水平均较对照组显著升高(均P<0.01)。咪达普利组和缬沙坦组内膜增生较高脂饮食组显著减轻(P<0.01)。CDK4、VCAM-1、STAT3在高脂组、咪达普利组和缬沙坦组中表达均较对照组显著增高(P<0.01);CDK4、VCAM-1、STAT3在咪达普利组和缬沙坦组中表达较高脂组显著减少(P<0.01)。P15mRNA表达在高脂组、咪达普利组和缬沙坦组均较对照组显著减少(P<0.01),在咪达普利组和缬沙坦组表达均较高脂组显著增高(P<0.01)。结论:咪达普利与缬沙坦可明显抑制动脉粥样硬化的发生,其机制与阻断STAT3信号转导通路、抑制内膜细胞增殖有关。 Objective:To investigate the effects of imidapril and valsartan on the expressions of cyclin-dependent kinase 4(CDK4),vascular cell adhesion molecule-1(VCAM-1),STAT3 and P15mRNA in rabbit aorta and the mechanism.Methods:Forty-eight rabbits were randomly divided into 4 groups:the control group,high cholesterol group,high cholesterol+imidapril group and high cholesterol+valsartan group.Artery blood samples were collected at the end of 8 weeks for examination of serum lipid levels.The expressions of CDK4,VCAM-1,STAT3 were detected by immunohistochemistry and the expressions of P15mRNA were detected by RT-PCR.Results:Rabbits fed with high-cholesterol diet showed higher serum lipid levels compared with those fed with normal diet(P0.01).The intimal lesion in imidapril treated group and valsartan treated group reduced significantly than those of high cholesterol group(P0.01).The expressions of CDK4,VCAM-1 and STAT3 in imidapril treated group and valsartan treated group decreased significantly than those of high cholesterol group(P0.01),while the expressions of P15 mRNA of imidapril and valsartan group were higher than those of high cholesterol group(P0.01).Conclusion:Imidapril,valsartan can inhibit atherosclerotic progression.The mechanism may be related to the inhibition of the proliferation of vascular smooth muscle cells in atherosclerosis.
作者 陈作元 马颖
出处 《中日友好医院学报》 2012年第1期21-24,F0003,共5页 Journal of China-Japan Friendship Hospital
关键词 咪达普利 缬沙坦 动脉粥样硬化 细胞周期蛋白依赖激酶4 血管细胞黏附分子-1 imidapril valsartan atherosclerosis cyclin-dependent kinase 4 vascular cell adhesion molecule-1
  • 相关文献

参考文献10

  • 1Sonoda M,Aoyagi T,Takenaka K,et al.A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients [J].Int Heart J, 2008,49: 95-103.
  • 2Hirata Y,Hayakawa H,Kakoki M,et al.Nitric oxide release from kidneys of hypertensive rats treated with imidapril[J]. Hypertension, 1996,27 : 672-678.
  • 3Fukuda D,Enomoto S,Nagai R,et al.Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation [J].Biomed Pharma- cother, 2009,63 ( 10) : 754-761.
  • 4陈云波,侯孟君,王奇,高国全,程淑意,赖世隆.半定量RT-PCR检测少量兔血管内皮细胞中特异mRNA的表达[J].广州中医药大学学报,2000,17(1):81-84. 被引量:4
  • 5Heo I-IJ,Yun MR,Jung KH,et al.Endogenous angiotension II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vcascular smooth muscle cells[J].Life Sci,2007,80:1057-1063.
  • 6Da Cunha V,Tham DM,Martin-McNuhy B,et al.Enalapril attenuates angiotension Ⅱ-induced atherosclerosis and vascular inflammation[J].Atheroselerosis, 2005,178 : 9-17.
  • 7孙文忠,徐志文,唐安洲,苏纪平.PTKs CDK4及p15在中耳胆脂瘤上皮的表达[J].临床耳鼻咽喉科杂志,2004,18(10):616-619. 被引量:7
  • 8Watanabe S,Mu W,Kahn A,et al.Role of JAK/STAT path- way in IL-6-induced activation of vascular smooth muscle cells.[J]Am J Nephrol,2004,24:387-392.
  • 9Foshay K,Rodriguez G,Hoel B,et al.JAK2 /STAT3 directs cardiomyogenesis within murine embryonic stern cells in vitro[J].Stem Cells, 2005,23:530-543.
  • 10Nagai N,Oike Y,Izumi-Nagai K,et al.Suppression of choroidal neovascularization by inhibiting angiotensin-con- verting enzyme:minimal role of bradykinin [J].Invest Ophthalmol Vis Sci,2007,48:2321 - 2326.

二级参考文献15

  • 1高国全,姚志彬,马涧泉.大鼠脑、肝和前列腺一氧化氮合酶mRNA表达[J].中山大学学报(医学科学版),1997,17(S1):30-33. 被引量:4
  • 2张晨晖,李倩虹,张继峰,周洪,张新波,汤健.一氧化氮合成酶(NOS)基因表达的半定量检测及其运用[J].生理学报,1994,46(4):347-354. 被引量:15
  • 3Kingston R E 见:(美)F.奥斯伯等著 颜子颖 王海林译.Po1y(A)^+RNA的制备[A].见:(美)F.奥斯伯等著.颜子颖,王海林译.精编分子生物学实验指南[C].北京:科学出版社,1998.130-131.
  • 4Braun-Dullaeus R C, Mann M J, Dzau V J. Cell cycle progression: new therapeutic target for vascular prolifera-tive disease. Circulation, 1998,98:82- 89.
  • 5Barford D, Das A K, Egloff M P. The structure and mechanism of protein phosphatases:insights into catalysis and regulation. Biophys Biomol Struct, 1998, 27 : 133-164.
  • 6Stevan R H, Moosa M, Joseph S. Autoregulatory mechanisms in protein-tyrosine kinases. J Biol Chem,1998,273 : 11987- 11990.
  • 7Bujia J,Kim C, Holly A,et al. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma:an analysis of protein production and gene expression.Am J Otol,1996,17:203-206.
  • 8Tanaka Y, Kojima H, Miyazaki H, et al. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium. Laryngoscope, 1999,109 : 1102 - 1107.
  • 9Park H J,Park K. Expression of Fas/APO-1 and apoptosis of keratinocytesin human cholesteatoma. Laryngoscope,1999,109 : 613-616.
  • 10Kojima H,Tanaka Y,Tanaka T, et al. Cell proliferation and apoptosis in human middle ear choleateatoma. Arch Otolaryngol Head Neck Surg, 1998,124: 261 - 264.

共引文献9

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部